title: Desperately seeking serotonin... A commentary on the withdrawal of tegaserod and the state of drug development for functional and motility disorders.
authors.affiliation: University of Texas Medical Branch, Gasveston, TX 77555, USA. jpasrich@utmb.edu
authors.forename: Pankaj Jay
authors.initials: PJ
authors.lastname: Pasricha
mesh_terms: D017277:Drug Approval; D005765:Gastrointestinal Agents / Q000009:adverse effects* / Q000627:therapeutic use; D005767:Gastrointestinal Diseases / Q000188:drug therapy*; D005769:Gastrointestinal Motility / Q000187:drug effects; D006801:Humans; D007211:Indoles / Q000009:adverse effects* / Q000627:therapeutic use; D043183:Irritable Bowel Syndrome / Q000188:drug therapy; D007511:Ischemia / Q000139:chemically induced; D008389:Marketing of Health Services; D017366:Serotonin Receptor Agonists / Q000009:adverse effects* / Q000627:therapeutic use; D013678:Technology, Pharmaceutical / Q000639:trends*; D014481:United States
chemical_list: D005765:Gastrointestinal Agents; D007211:Indoles; D017366:Serotonin Receptor Agonists; C105050:tegaserod